Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Three in five adults with ASCVD have systemic inflammation, which is associated with excess healthcare resource utilization and increased rates of cardiovascular events and death.
Authors
- Anne‐Laure Faucon (ORCID: https://orcid.org/0000-0001-6716-1157)
- Simon Bertram Reuter (ORCID: https://orcid.org/0000-0002-2256-2034)
- Roxana Mehran (ORCID: https://orcid.org/0000-0002-5546-262X)
- Nikolaus Marx (ORCID: https://orcid.org/0000-0001-6141-634X)
- Sofia Gerward
- Edouard L. Fu (ORCID: https://orcid.org/0000-0002-9698-6825)
- Juan Jesús Carrero (ORCID: https://orcid.org/0000-0003-4763-2024)
- Faizan Mazhar (ORCID: https://orcid.org/0000-0002-2818-1179)
- Karolina Szummer (ORCID: https://orcid.org/0000-0002-0994-8135)
- Jimmi Mathisen (ORCID: https://orcid.org/0000-0002-7391-7296)
Institutions
- Mount Sinai Health System (US)
- Karolinska University Hospital (SE)
- Novo Nordisk (Denmark) (DK)
- Leiden University Medical Center (NL)
- Danderyds sjukhus (SE)
- Karolinska Institutet (SE)
- Glanrhyd Hospital (GB)
- RWTH Aachen University (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/eurheartj/ehae557
- Citations
- 56
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 32.08
Funders
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- National Institutes of Health